WC
OCEA

Wexford Capital’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Wexford Capital’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-33,310
Closed -$22K – 293
2023
Q4 		$22K Buy
+33,310
New +$45.7K ﹤0.01% 188

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wexford Capital's OCEA Position: Q1 2024 in Review

Wexford Capital sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2024, closing a stake of 33,310 shares — an estimated $22K sold.

Wexford Capital first reported a position in OCEA in Q4 2023 and held it in 1 quarter. The position peaked at $22K in Q4 2023. 46 funds tracked by Wall St. Rank hold OCEA as of Q1 2024.

  • Wexford Capital reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Wexford Capital sold 33,310 Ocean Biomedical, Inc. Common Stock shares in Q1 2024, an estimated $22K.
  • Wexford Capital first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Wexford Capital's Ocean Biomedical, Inc. Common Stock position peaked at $22K in Q4 2023.
  • 46 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2024.

Based on Wexford Capital's 13F filing for Q1 2024, filed 15 May 2024.